MISSION PRODUCE, INC. (AVO): what the price assumes

Generated: 2026-07-29 · Source: https://boothcheck.com/report/AVO

Headline

Field	Value
Ticker	AVO
Company	MISSION PRODUCE, INC.
Sector / Industry	Basic Materials
Current price	$12.89/sh

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

Field	Value
Inversion basis	whole-company
Operating margin (value-band context)	1.5%
Operating margin today	3.6%
Margin compression (value-band)	-2.1pp
Implied growth	19.2%
Multiple paid	29x operating income

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 8.1% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~8.3pp.

Reconcile: at the x-ray's 9.3% required return this reads ~5.8 years; the models below use their own rates.

How unusual the bet is: within-range

Reference	Value
vs own history	-0.23σ
sustained it ~5 years at this level	38%
implied end-window share	0%

Valuation X-Ray

Every valuation family lands below the price. The price therefore sits beyond what those standard frames encode.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Family	Median price/FV	Models	Reads
Asset	5.95x	4	expensive
Earnings	7.18x	4	expensive
Relative	1.43x	3	expensive
Growth	2.18x	3	expensive

Families that call it expensive: Asset, Earnings, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.0%); the inversion above states its own rate.

Per-Model Detail (n=14)

Model	Family	FV	Price/FV	Applicable	Methodology
DCF Perpetual Growth	Growth	$1.94	6.64x	yes	FCF base $0.0B, growth -10% (input: historical growth), terminal g 0.5%, WACC 8.0%, 5yr projection
DCF Exit Multiple	Growth	$10.56	1.22x	yes	Exit EV/EBITDA: 14.4x / 16.4x / 18.4x (bear / base = today's held flat / bull), 5yr
Relative Valuation	Relative	$9.03	1.43x	yes	P/E 27.57x (blended: static sector reference 18x + trailing (TTM) 50x), scenarios: 23.4x / 27.6x / 31.7x (bear / base = reference held flat / bull), EV/EBITDA 12x
Simple DDM	Growth	—	—	no	—
Two-Stage DDM	Growth	—	—	no	—
Simple Excess Return	Asset	$2.79	4.62x	yes	BV/sh $6.55, ROE (TTM) 3.9%, ke 9.3%
Two-Stage Excess Return	Asset	$1.77	7.28x	yes	5yr excess ROE then converge to ke=9.3%
Discounted Future Market Cap	Growth	$5.92	2.18x	yes	Rev $1.2B, growth -10% (input: historical growth; tapered), Terminal P/S: 0.8x / 0.9x / 1.1x (bear / base = today's held flat / bull, cap 8x)
Growth-Adjusted P/E	Relative	—	—	no	—
Margin Trajectory	Growth	—	—	no	—
Earnings Power Value	Earnings	$1.26	10.23x	yes	Normalized EBIT (5y avg op income, one-time charges added back) $0.03B × (1−21%) / WACC 8.0% → EPV (no growth)
Residual Income	Asset	$1.39	9.27x	yes	BV $6.55 + 5yr PV of (ROE (TTM) 3.9% − Kₑ 9.3%) × BV; BV grows 2.6%/yr
Graham Number	Asset	$6.97	1.85x	yes	√(22.5 × EPS $0.33 × BVPS $6.55) — Graham's conservative floor
EV/EBITDA Relative	Relative	$8.96	1.44x	yes	EBITDA $0.08B × sector EV/EBITDA 12.0x
FCF Yield	Earnings	$2.38	5.41x	yes	FCF $34.3M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF Yield	Earnings	$1.44	8.95x	yes	SBC-adj FCF $0.03B (FCF $0.03B − SBC $0.01B) capitalized at Kₑ
Ben Graham Formula	Earnings	$0.28	46.02x	yes	EPS $0.33 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) (excluded from median)
ROIC-Justified P/B	Asset	—	—	no	—
P/Sales Sector	Relative	$35.28	0.37x	yes	Revenue $1.25B × sector P/S 2.5x
PEG Fair Value	Relative	—	—	no	—
Earnings Yield	Earnings	$3.57	3.61x	yes	EPS $0.33 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations Multiple	Relative	—	—	no	—
Clinical Phase NPV	Growth	—	—	no	—
Merton	Asset	—	—	no	—
V5 Mechanical	—	—	—	no	—

Solvency

Field	Value
Net debt	$109.5m
Net debt / NOPAT (after-tax)	3.11x
Net debt / operating income (pre-tax)	2.46x
Interest coverage	5.4x
Share count CAGR (dilution)	0.0%
Burning cash	no

Bullet Takeaways

• Mission Produce is two businesses stapled together: a distribution network that sources fruit from third-party growers, and an owned-orchard farming arm whose FY2025 sales in our International Farming segment increased $61.0 million or 94% with segment operating profit up 161 percent.
• Every family of valuation method lands below the price, which makes this a bet on the farming arm compounding rather than on the distribution business being mispriced.
• The share count has not grown at all over the last four years, so the owner of this equity is not funding the orchard build-out through dilution.

Bull Case

Start with what management does with the cash, because it is the least ambiguous thing in the file. The share count is flat over four years. No serial equity raises, no drift in the denominator, no quiet funding of growth out of shareholders' claim on the business. That matters more here than it would at most companies, because planting orchards is a long-dated capital commitment and the easy way to fund one is to sell stock into it. Mission Produce has not.

What the capital bought is now visible in the numbers. The FY2025 filing reports that sales in our International Farming segment increased $61.0 million or 94% in fiscal year 2025 compared to the previous year and segment operating profit increased $21.4 million or 161% in fiscal year 2025 compared to the previous year. The increases were driven by higher yield from owned avocado orchards as well as higher volume. A 161 percent move in segment profit against a 94 percent move in sales is operating leverage arriving, and it arrives from trees that were planted years earlier and are only now bearing at maturity.

The structural point is that the two halves reinforce each other. The company describes International Farming as owning and operates orchards from which the vast majority of fruit produced is sold to our Marketing & Distribution segment, so the farming arm is not competing for shelf space, it is feeding a network that already has it. The distribution side of that network is genuinely hard to replicate: the filing notes its footprint puts us in close proximity to our customers, allowing us to provide fruit based on customer timing, specification, and volume needs. Within the United States, we can deliver avocados within approximately eight hours or less. Eight hours is a logistics fact with a margin consequence, because ripeness is perishable and a supplier who can hit a narrow window gets paid for it.

Interest is covered better than five times over on the trailing year, and the balance sheet is not the constraint on the plan. For a business whose growth lever is biological and slow, being able to fund the next planting cycle out of operations rather than out of the equity or the credit market is most of what the bull case needs.

Bear Case

Avocado economics run on a cycle that nothing in a quarterly print reveals, and this price is being set near the good part of one. Trailing operating income of 44.5 million dollars for the year ending in April 2026 comes off a 3.6 percent operating margin on roughly 1.25 billion of revenue. That is a thin margin by construction, because most of the revenue passes through a distribution business that buys fruit from third parties and resells it. When the crop is short and prices are high, the farming arm earns well and the distribution arm gets squeezed. When the crop is long, the arithmetic reverses. A single year of 161 percent segment profit growth is a point on that cycle, not a trend line.

The customer side offers no offset. The filing is direct that Changes in our customers' strategies or purchasing patterns, including a reduction or increase in the number of suppliers from which they purchase, may adversely affect our sales. Additionally, our customers may face financial or other difficulties which may impact their operations and cause them to reduce their level of purchasing. Produce buyers at scale are grocery chains, and a grocery chain adding a second avocado supplier is an ordinary procurement decision with an immediate revenue consequence here.

Capacity is the part that compounds slowly and then arrives all at once. Orchards planted across the industry during a high-price stretch bear fruit whether or not prices are still high when they do. The company's own advantage this year, higher yield from owned avocado orchards, is available to every grower who planted on the same signal, and the supply that results does not respond to demand for several years. That is the specific mechanism by which a good crop year turns into a bad price year, and a 28.9 times multiple on trailing operating profit does not carry much room for it.

Finally, note where the methods land. This is not a case where one conservative family disagrees with the rest. Asset value, earnings power, peer multiples and forward growth all sit below the price. When every frame is below, the premium is not a disagreement about method, it is a bet the frames do not encode.

Valuation

The price embeds a growth requirement, and the useful way to read it is against what the business has demonstrated. Today's price prices the company at about 28.9 times trailing operating profit, which works back to a requirement of about 19.2 percent annual operating-income growth at an 8.1 percent cost of capital. Set that against a business whose own operating-income history places the requirement close to its historical middle rather than at an extreme: the assumption is demanding, but it is not unprecedented for this company.

Name the period, because it is not the obvious one. The 44.5 million dollar operating income figure is a trailing year ending 30 April 2026, rebuilt by deriving the untagged fiscal fourth quarter from the annual filing rather than by summing four discrete quarterly tags. That distinction is why the figure agrees with the filed statements exactly, and it is the base every multiple below rests on.

The disagreement among methods is unusually one-sided. The price sits above the peer-multiple family by roughly half again, above the forward-growth family by a bit over two times, above the asset family by close to six times, and above the earnings-power family by around seven. Nothing reaches the price. That pattern is the whole valuation question stated plainly: the standard frames all measure what the distribution business earns today, and the price is paying for what the orchards produce later. Whether that is a premium or a mistake depends entirely on the yield curve of trees already in the ground, which no valuation family models.

Solvency does not complicate the story. Interest is covered more than five times over on the trailing year, funded borrowings run about 2.5 times operating profit before tax and 3.1 times after it, and the share count has not moved in four years. There is no burn, no dilution, and no refinancing wall pressing on the timeline. That leaves the case resting where it should: on whether the farming arm's step up in profit was the beginning of a curve or the top of a cycle.

Catalysts

The next real information event is the fiscal-year print, and the specific line to watch is International Farming, not consolidated revenue. The FY2025 filing attributes its move to higher yield from owned avocado orchards as well as higher volume, and a second consecutive year of yield-driven segment profit growth would separate a maturing orchard base from a favourable crop year. Consolidated revenue will not distinguish those two, because the distribution segment's revenue moves with fruit prices in the opposite direction from the farming segment's margins.

Blueberries is the smaller variable and the one with the least history behind it. The company reports it as its own segment, financed as the filing describes through shareholder contributions and loans, as well as short-term bank borrowings, which is a different funding posture from the avocado business and worth watching for what it says about management's confidence in that expansion.

Beyond that, the honest answer is that the drivers here are agricultural and slow. Planting decisions made across the industry during the last high-price stretch will reach bearing age on their own schedule regardless of what any quarter reports, and that supply, once it arrives, is the event that matters most to this price.

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.